| 12398146 |
Heterobicyclic amides as inhibitors of CD38 |
Laurie B. Schenkel, Melissa Marie Vasbinder, Nicholas Robert Perl, Jennifer R. Downing |
2025-08-26 |
|
| 12371421 |
Solid forms of a PARP7 inhibitor |
Melissa Marie Vasbinder, Laurie B. Schenkel, Kerren Kalai Swinger, Jun Xu, Meng Jiang +1 more |
2025-07-29 |
|
| 12251386 |
Salt form of a human histone methyltransferase EZH2 inhibitor |
Kuan-Chun Huang, Hyeong Wook Choi, Kristen Sanders, Steven Mathieu, Arani Chanda +1 more |
2025-03-18 |
|
| 12168015 |
Aryl-or heteroaryl-substituted benzene compounds |
Richard Chesworth, Kenneth W. Duncan, Heike KEILHACK, Natalie Warholic, Christine Klaus +5 more |
2024-12-17 |
|
| 12168016 |
Aryl-OR heteroaryl-substituted benzene compounds |
Richard Chesworth, Kenneth W. Duncan, Heike KEILHACK, Natalie Warholic, Christine Klaus +5 more |
2024-12-17 |
|
| 12161645 |
Aryl-or heteroaryl-substituted benzene compounds |
Richard Chesworth, Kenneth W. Duncan, Heike KEILHACK, Natalie Warholic, Christine Klaus +5 more |
2024-12-10 |
|
| 11987584 |
Heterobicyclic amides as inhibitors of CD38 |
Laurie B. Schenkel, Melissa Marie Vasbinder, Nicholas Robert Perl, Jennifer R. Downing |
2024-05-21 |
|
| 11958837 |
Quinazolinones as PARP14 inhibitors |
Laurie B. Schenkel, Melissa Marie Vasbinder, Kerren Kalai Swinger |
2024-04-16 |
|
| 11952377 |
Quinolines and azaquinolines as inhibitors of CD38 |
Jennifer R. Downing, Laurie B. Schenkel, Melissa Marie Vasbinder |
2024-04-09 |
|
| 11691969 |
Pyridazinones as PARP7 inhibtors |
Nicholas Robert Perl, Melissa Marie Vasbinder |
2023-07-04 |
|
| 11642348 |
Substituted benzene compounds |
John Emmerson Campbell, Masashi Seki, Syuji Shirotori, Wataru Itano, Wanjun Zheng |
2023-05-09 |
|
| 11633420 |
Method of treating leukemia |
Edward J. Olhava, Richard Chesworth, Victoria M. Richon, Roy M. Pollock, Scott R. Daigle |
2023-04-25 |
|
| 11566020 |
Pyridazinones as PARP7 inhibitors |
Melissa Marie Vasbinder, Laurie B. Schenkel, Kerren Kalai Swinger |
2023-01-31 |
|
| 11535621 |
Heterobicyclic amides as inhibitors of CD38 |
Laurie B. Schenkel, Melissa Marie Vasbinder, Nicholas Robert Perl, Jennifer R. Downing |
2022-12-27 |
|
| 11491163 |
Salt form of a human histone methyltransferase EZH2 inhibitor |
Kuan-Chun Huang, Hyeong Wook Choi, Kristen Sanders, Steven Mathieu, Arani Chanda +1 more |
2022-11-08 |
|
| 11370781 |
Combination therapy for treating cancer |
Heike KEILHACK, Sarah K. Knutson |
2022-06-28 |
$6,489,000 |
| 11293927 |
Screening methods for PARP modulators |
Timothy J.N. Wigle, Danielle Johnston BLACKWELL, Melissa Marie Vasbinder, Laurie B. Schenkel, Kerren Kalai Swinger |
2022-04-05 |
|
| 11052093 |
Aryl-or heteroaryl-substituted benzene compounds |
Richard Chesworth, Kenneth W. Duncan, Heike KEILHACK, Natalie Warholic, Christine Klaus +5 more |
2021-07-06 |
$11,691,000 |
| 11014913 |
Pyridazinones as PARP7 inhibitors |
Melissa Marie Vasbinder, Laurie B. Schenkel, Kerren Kalai Swinger |
2021-05-25 |
|
| 11008308 |
Quinazolinones as PARP14 inhibitors |
Laurie B. Schenkel, Melissa Marie Vasbinder, Kerren Kalai Swinger |
2021-05-18 |
|
| 10881680 |
Method of treating leukemia |
Edward J. Olhava, Richard Chesworth, Victoria M. Richon, Roy M. Pollock, Scott R. Daigle |
2021-01-05 |
$18,341,000 |
| 10870641 |
Pyridazinones as PARP7 inhibitors |
Melissa Marie Vasbinder, Laurie B. Schenkel, Kerren Kalai Swinger |
2020-12-22 |
|
| 10821113 |
Salt form of a human histone methyltransferase EZH2 inhibitor |
Kuan-Chun Huang, Hyeong Wook Choi, Kristen Sanders, Steven Mathieu, Arani Chanda +1 more |
2020-11-03 |
$20,506,000 |
| 10787440 |
Combination therapy for treating cancer |
Heike KEILHACK, Sarah K. Knutson |
2020-09-29 |
$9,371,000 |
| 10710987 |
Hydrochloride salt form for EZH2 inhibition |
Hyeong Wook Choi, Steven Mathieu, Kristen Sanders, Arani Chanda |
2020-07-14 |
$23,216,000 |